The success of a Pharmaceutical company is its ability to develop products to the highest standard in support of its marketing requirements and portfolio therapeutic classifications while remaining cost effective in order to service global markets.
LIFEPharma has a world-class R&D Centre with state of the art equipment and highly competent, qualified personnel. Our R&D equipment complements our manufacturing facility thus making technical-transfer an easy and smooth process.
Our technology development team consists of scientists drawn from some of the best research organizations. Our highly qualified professionals, their capability, depth of experience combined with our state of the art facility, provides a strong base for future success which is constantly strengthened by the addition of new technologies and the ongoing improvement of our current processes.
Through a combination of state-of-the art process equipment, analytical instrumentation, infrastructure that meets global development standards and world-class expertise, LifePharma meets all the requirements of modern pharmaceutical development aimed at the most highly regulated markets in the world.
At LIFEPharma, our new product development program includes pre-formulation studies, excipient compatibility studies, analytical methods development and validation, formulation development and optimization, stability studies and manufacturing process development according to ICH Guidelines. We also have a program dedicated to the continuous improvement of existing products at our specialized Research and Development site.
Our Development operation and support laboratories are well-equipped to handle:
This new arm of the company will develop new products in dosage form for us to manufacture, including:
LIFEPharma’s purpose is to bring therapies that reach patients across the globe. To develop our formulations we bring together advanced science and the newest technologies.
Check back to see our progress on this exciting new prospect for LIFEPharma.
Development timelines for injections 12-15 months; solids 18-20 months (estimated).
QbD guidelines followed at every step.